Molecular mechanisms regulating the tumor-targeting potential of splice-activated gene expression
- 10 September 2004
- journal article
- research article
- Published by Springer Nature in Cancer Gene Therapy
- Vol. 11 (12) , 797-807
- https://doi.org/10.1038/sj.cgt.7700759
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Adenoviral vectors: Systemic delivery and tumor targetingCancer Gene Therapy, 2002
- Novel chimeric gene promoters responsive to hypoxia and ionizing radiationGene Therapy, 2002
- Alternative splicing as a novel of means of regulating the expression of therapeutic genesCancer Gene Therapy, 2002
- Alternatively Spliced CD44 Isoforms Containing Exon v10 Promote Cellular Adhesion through the Recognition of Chondroitin Sulfate-Modified CD44Experimental Cell Research, 1999
- ALTERNATIVE SPLICING OF PRE-mRNA: Developmental Consequences and Mechanisms of RegulationAnnual Review of Genetics, 1998
- The normal structure and function of CD44 and its role in neoplasiaMolecular Pathology, 1998
- CD44: Structure, Function and Association with the Malignant ProcessPublished by Elsevier ,1997
- From Transcript to ProteinCell, 1996
- To metastasize or not? Selection of CD44 splice sitesNature Medicine, 1995
- Molecular cloning of CD44R1 and CD44R2, two novel isoforms of the human CD44 lymphocyte "homing" receptor expressed by hemopoietic cells.The Journal of Experimental Medicine, 1991